Prof Christina Peters speaks to ecancer about her presentation at ALL Assembly 2021 on post-HSCT (haematopoietic stem cell transplantation) management of paediatric patients with acute lymphoblastic leukaemia (ALL).

She explains that the session focused on how to prevent relapse in patients with high-risk features, going into detail on how patients are monitored and managed post-transplant to minimise chances of relapse.